Mikkael Sekeres and Justin Watts (IMAGE)

University of Miami Miller School of Medicine

Mikkael Sekeres and Justin Watts

Caption

A new generation of targeted treatments and gentler chemotherapy options for older adults with a new diagnosis of acute myeloid leukemia (AML) is driving better survival and cure rates. The updated 2025 American Society of Hematology (ASH) AML treatment guidelines, appear Dec. 1, 2025, in the journal Blood Advances.In addition, the updated guidelines will be presented Dec . 7 at the American Society of Hematology (ASH) annual meeting in Orlando.

Credit

Sylvester Comprehensive Cancer Center

Usage Restrictions

Use with attribution

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.